chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Was sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Was sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Was sick). At the time of the report, ILLNESS (Was sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported. Due to various circumstances the patient does not received the second dose of the vaccine.   This case was linked to MOD-2021-406188 (Patient Link).   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Skin reaction
Clinical narrative: she had a delayed reaction; The area is Itchy when it comes out and itchy when it starts to fade out; Rash below the neck, upper tights, around left elbow, chest & back area; This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (she had a delayed reaction), RASH PRURITIC (The area is Itchy when it comes out and itchy when it starts to fade out) and RASH (Rash below the neck, upper tights, around left elbow, chest & back area) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced SKIN REACTION (she had a delayed reaction), RASH PRURITIC (The area is Itchy when it comes out and itchy when it starts to fade out) and RASH (Rash below the neck, upper tights, around left elbow, chest & back area). The patient was treated with CORTISONE for Itching, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, SKIN REACTION (she had a delayed reaction) outcome was unknown and RASH PRURITIC (The area is Itchy when it comes out and itchy when it starts to fade out) and RASH (Rash below the neck, upper tights, around left elbow, chest & back area) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided. 14 days after the booster shot, the patient had a delayed reaction. She had a rash below the neck, upper tights and arm around left elbow, chest and back area. Looks like rosacea but it was not rosacea. The area was Itchy when it comes out and itchy when it starts to fade out.   This case was linked to MOD-2021-406092 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dizziness, Malaise, Vaccination site pain
Clinical narrative: uneasy; not feeling good; lightheaded, not as bad, still had lightheadedness, still a little lightheaded; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (uneasy), MALAISE (not feeling good), DIZZINESS (lightheaded, not as bad, still had lightheadedness, still a little lightheaded) and VACCINATION SITE PAIN (sore left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939909, 036A21A and 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (Patient takes a water pill to treat high blood pressure).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (sore left arm). On 04-Dec-2021, the patient experienced MALAISE (not feeling good) and DIZZINESS (lightheaded, not as bad, still had lightheadedness, still a little lightheaded). On 07-Dec-2021, the patient experienced DISCOMFORT (uneasy). At the time of the report, DISCOMFORT (uneasy) and DIZZINESS (lightheaded, not as bad, still had lightheadedness, still a little lightheaded) had not resolved and MALAISE (not feeling good) and VACCINATION SITE PAIN (sore left arm) outcome was unknown.            Treatment information was not provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Musculoskeletal discomfort, Musculoskeletal stiffness, Neck pain, Pain
Clinical narrative: very big pain; Bruise in injection site; Neck is swollen; neck is very very sore; neck is stiff; can't pop up my neck; can't swallow; Rash was described as red little bumps and itchy; rash,rash in upper legs and upper arms; fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (very big pain), VACCINATION SITE BRUISING (Bruise in injection site), SWELLING (Neck is swollen), NECK PAIN (neck is very very sore) and MUSCULOSKELETAL STIFFNESS (neck is stiff) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LAMOTRIGINE (LAMICTAL) for Convulsions.    On 01-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (very big pain), VACCINATION SITE BRUISING (Bruise in injection site), SWELLING (Neck is swollen), NECK PAIN (neck is very very sore), MUSCULOSKELETAL STIFFNESS (neck is stiff), MUSCULOSKELETAL DISCOMFORT (can't pop up my neck), DYSPHAGIA (can't swallow), URTICARIA (Rash was described as red little bumps and itchy), RASH (rash,rash in upper legs and upper arms) and PYREXIA (fever). At the time of the report, PAIN (very big pain), VACCINATION SITE BRUISING (Bruise in injection site), SWELLING (Neck is swollen), NECK PAIN (neck is very very sore), MUSCULOSKELETAL STIFFNESS (neck is stiff), MUSCULOSKELETAL DISCOMFORT (can't pop up my neck), DYSPHAGIA (can't swallow), URTICARIA (Rash was described as red little bumps and itchy) and PYREXIA (fever) outcome was unknown and RASH (rash,rash in upper legs and upper arms) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Swelling, Urticaria, Vaccination site bruising
Clinical narrative: very big pain; Bruise in injection site; Neck is swollen; neck is very very sore; neck is stiff; can't pop up my neck; can't swallow; Rash was described as red little bumps and itchy; rash,rash in upper legs and upper arms; fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (very big pain), VACCINATION SITE BRUISING (Bruise in injection site), SWELLING (Neck is swollen), NECK PAIN (neck is very very sore) and MUSCULOSKELETAL STIFFNESS (neck is stiff) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LAMOTRIGINE (LAMICTAL) for Convulsions.    On 01-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (very big pain), VACCINATION SITE BRUISING (Bruise in injection site), SWELLING (Neck is swollen), NECK PAIN (neck is very very sore), MUSCULOSKELETAL STIFFNESS (neck is stiff), MUSCULOSKELETAL DISCOMFORT (can't pop up my neck), DYSPHAGIA (can't swallow), URTICARIA (Rash was described as red little bumps and itchy), RASH (rash,rash in upper legs and upper arms) and PYREXIA (fever). At the time of the report, PAIN (very big pain), VACCINATION SITE BRUISING (Bruise in injection site), SWELLING (Neck is swollen), NECK PAIN (neck is very very sore), MUSCULOSKELETAL STIFFNESS (neck is stiff), MUSCULOSKELETAL DISCOMFORT (can't pop up my neck), DYSPHAGIA (can't swallow), URTICARIA (Rash was described as red little bumps and itchy) and PYREXIA (fever) outcome was unknown and RASH (rash,rash in upper legs and upper arms) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product administered to patient of inappropriate age, Wrong technique in product usage process
Clinical narrative: the patient received their 2nd dose with Pfizer on 5Dec2021; a 15 year old patient received the Moderna Covid-19 Vaccine as their 1st dose; the office that gave the 1st dose actually gave it as two 0.25 ml doses separated by 5 hours on the same day; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 15 year old patient received the Moderna Covid-19 Vaccine as their 1st dose), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the office that gave the 1st dose actually gave it as two 0.25 ml doses separated by 5 hours on the same day) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the patient received their 2nd dose with Pfizer on 5Dec2021) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 0.5 milliliter. On 05-Dec-2021, the patient received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 15 year old patient received the Moderna Covid-19 Vaccine as their 1st dose) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the office that gave the 1st dose actually gave it as two 0.25 ml doses separated by 5 hours on the same day). On 05-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the patient received their 2nd dose with Pfizer on 5Dec2021). On 09-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 15 year old patient received the Moderna Covid-19 Vaccine as their 1st dose) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the office that gave the 1st dose actually gave it as two 0.25 ml doses separated by 5 hours on the same day) had resolved. On 05-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the patient received their 2nd dose with Pfizer on 5Dec2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm hurts so much; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (Arm hurts so much) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurts so much). At the time of the report, VACCINATION SITE PAIN (Arm hurts so much) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Pain in extremity
Clinical narrative: achy all over for 2-3 days in legs; generalized weakness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Dec-2021 and was forwarded to Moderna on 07-Dec-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (achy all over for 2-3 days in legs) and ASTHENIA (generalized weakness) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A1A and 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE, ATORVASTATIN and METOPROLOL for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (achy all over for 2-3 days in legs) and ASTHENIA (generalized weakness). At the time of the report, PAIN IN EXTREMITY (achy all over for 2-3 days in legs) and ASTHENIA (generalized weakness) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-406103 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: dose administered after vial had been punctured >12 hours; Max temp was 71.2 degrees F, min temp 65.4 degrees F. Lot number 031H21A. Vial was moved from freezer to fridge on 11/17/21.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after vial had been punctured >12 hours) and PRODUCT STORAGE ERROR (Max temp was 71.2 degrees F, min temp 65.4 degrees F. Lot number 031H21A. Vial was moved from freezer to fridge on 11/17/21.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after vial had been punctured >12 hours) and PRODUCT STORAGE ERROR (Max temp was 71.2 degrees F, min temp 65.4 degrees F. Lot number 031H21A. Vial was moved from freezer to fridge on 11/17/21.). In November 2021, EXPIRED PRODUCT ADMINISTERED (dose administered after vial had been punctured >12 hours) and PRODUCT STORAGE ERROR (Max temp was 71.2 degrees F, min temp 65.4 degrees F. Lot number 031H21A. Vial was moved from freezer to fridge on 11/17/21.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication were reported.   No treatment drug were reported.    Vial was at room temperature from 3 pm the previous day until 9:30 am the next day. The vial was punctured at 3 pm the previous day. Max temp was 71.2 degrees F, min temp 65.4 degrees F. Vial was moved from freezer to fridge on 17-Nov-21.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired doses administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter stated that patient was on concomitant medications. No treatment details were reported.  Reporter also stated that patient did not experienced any symptoms.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lymphadenopathy
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (typical flu-like symptoms after receiving the first two doses) and LYMPHADENOPATHY (lymphadenopathy after second dose) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 019B21A) for COVID-19 vaccination. The patient's past medical history included Anaphylaxis. Concurrent medical conditions included Asthma. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for Asthma, METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), SERTRALINE HYDROCHLORIDE (ZOLOFT), LEVOTHYROXINE, SPIRONOLACTONE, LEVETIRACETAM (KEPRA), TRAZODONE, MONTELUKAST SODIUM (SINGULAIR), FAMOTIDINE (PEPCID [FAMOTIDINE]), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), MELATONIN and SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]) for an unknown indication.On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (typical flu-like symptoms after receiving the first two doses) and LYMPHADENOPATHY (lymphadenopathy after second dose). At the time of the report, INFLUENZA LIKE ILLNESS (typical flu-like symptoms after receiving the first two doses) outcome was unknown and LYMPHADENOPATHY (lymphadenopathy after second dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medication use was reported. This case was linked to MOD-2021-406115 (Patient Link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Peripheral swelling
Clinical narrative: mild allergic reaction after booster arm is swelling in a way it didn't for the other two; burned in arm when it went in; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (mild allergic reaction after booster arm is swelling in a way it didn't for the other two) and BURNING SENSATION (burned in arm when it went in) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 019B21A and 019B21A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis. Concurrent medical conditions included Asthma. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for Asthma, METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), SERTRALINE HYDROCHLORIDE (ZOLOFT), LEVOTHYROXINE, SPIRONOLACTONE, LEVETIRACETAM (KEPRA), TRAZODONE, MONTELUKAST SODIUM (SINGULAIR), FAMOTIDINE (PEPCID [FAMOTIDINE]), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), MELATONIN and SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]) for an unknown indication.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, the patient experienced PERIPHERAL SWELLING (mild allergic reaction after booster arm is swelling in a way it didn't for the other two) and BURNING SENSATION (burned in arm when it went in). At the time of the report, PERIPHERAL SWELLING (mild allergic reaction after booster arm is swelling in a way it didn't for the other two) and BURNING SENSATION (burned in arm when it went in) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication use was reported.   This case was linked to MOD-2021-406115, MOD-2021-406125 (Patient Link).
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired doses administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered to patients) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered to patients). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (expired doses administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant informations were reported.  No Treatment informations were reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired doses administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications include nasal spray.  No treatment medications provided.  Patient did not experience any events.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain
Clinical narrative: pains for a couple of days after dose 1 and dose 2, it hurt a lot after dose 1; aches for a couple of days after dose 1 and dose 2, different muscles in his body were hurting after dose 1; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pains for a couple of days after dose 1 and dose 2, it hurt a lot after dose 1) and MYALGIA (aches for a couple of days after dose 1 and dose 2, different muscles in his body were hurting after dose 1) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 vaccination.     The patient's past medical history included Flu-like symptoms (few months ago before the first dose). Concurrent medical conditions included HIV disease. Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR), ATOMOXETINE HYDROCHLORIDE (STRATTERA), BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) and TRAZODONE for an unknown indication.    On 04-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pains for a couple of days after dose 1 and dose 2, it hurt a lot after dose 1) and MYALGIA (aches for a couple of days after dose 1 and dose 2, different muscles in his body were hurting after dose 1). The patient was treated with IBUPROFEN for Adverse event, at a dose of 800 mg. At the time of the report, PAIN (pains for a couple of days after dose 1 and dose 2, it hurt a lot after dose 1) and MYALGIA (aches for a couple of days after dose 1 and dose 2, different muscles in his body were hurting after dose 1) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included clonathan.   This case was linked to MOD-2021-406167 (Patient Link).
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema nodosum, Lymphadenopathy, Rash
Clinical narrative: Yesterday was diagnosed with erythema nodosum / developed joint pain in lower extremities & a rash on shins; a rash on shins; a week ago she developed joint pain in lower extremities; swollen lymph nodes in left arm just above the elbowand in axillary; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA NODOSUM (Yesterday was diagnosed with erythema nodosum / developed joint pain in lower extremities & a rash on shins), RASH (a rash on shins), LYMPHADENOPATHY (swollen lymph nodes in left arm just above the elbowand in axillary) and ARTHRALGIA (a week ago she developed joint pain in lower extremities) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Oct-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in left arm just above the elbowand in axillary). In November 2021, the patient experienced RASH (a rash on shins) and ARTHRALGIA (a week ago she developed joint pain in lower extremities). On 06-Dec-2021, the patient experienced ERYTHEMA NODOSUM (Yesterday was diagnosed with erythema nodosum / developed joint pain in lower extremities & a rash on shins). At the time of the report, ERYTHEMA NODOSUM (Yesterday was diagnosed with erythema nodosum / developed joint pain in lower extremities & a rash on shins), RASH (a rash on shins), LYMPHADENOPATHY (swollen lymph nodes in left arm just above the elbowand in axillary) and ARTHRALGIA (a week ago she developed joint pain in lower extremities) had not resolved.            No concomitant medication were reported. No treatment information was provided by the reporter.  Shortly after getting the 2nd dose, patient developed swollen lymph nodes in left arm just above the elbow and in axillary. The symptoms continued to get worse and a week ago in NOV-2021 patient developed joint pain in her lower extremities & a rash on shins. Patient was diagnosed with erythema nodosum ON 06-DEC-2021. Patient mentioned of seeing a rheumatologist soon.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site reaction
Clinical narrative: Covid arm; experiencing a rash around the spot where they injected the needle in her arm; That area was red and itchy as well; That area was red and itchy as well; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE RASH (experiencing a rash around the spot where they injected the needle in her arm), VACCINATION SITE ERYTHEMA (That area was red and itchy as well) and VACCINATION SITE PRURITUS (That area was red and itchy as well) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE RASH (experiencing a rash around the spot where they injected the needle in her arm), VACCINATION SITE ERYTHEMA (That area was red and itchy as well) and VACCINATION SITE PRURITUS (That area was red and itchy as well). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 24-Mar-2021, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE RASH (experiencing a rash around the spot where they injected the needle in her arm), VACCINATION SITE ERYTHEMA (That area was red and itchy as well) and VACCINATION SITE PRURITUS (That area was red and itchy as well) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  She took Tylenol for her symptoms and it went away in 1 or 2 days.   This case was linked to MOD-2021-406161, MOD-2021-406164, MOD-2021-406162 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (I couldn't use my left arm) and VACCINATION SITE PAIN (My arm was sore at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I couldn't use my left arm) and VACCINATION SITE PAIN (My arm was sore at injection site). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (I couldn't use my left arm) and VACCINATION SITE PAIN (My arm was sore at injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-406205 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Is itching a normal side effect; This spontaneous case was reported by a pharmacist and describes the occurrence of PRURITUS (Is itching a normal side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Is itching a normal side effect). At the time of the report, PRURITUS (Is itching a normal side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided. No treatment information were given.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (after expiration date) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A, 023M20A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (after expiration date). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (after expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Patient had not reported any symptoms and had not received any treatments.    This case was linked to MOD-2021-406177 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (after expiration date) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A, 023M20A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (after expiration date). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (after expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was unknown.   This case was linked to MOD-2021-406176 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (has limited movement in left arm says can't use it to put seatbelt on), PYREXIA (feverish) and VACCINATION SITE PAIN (left arm pain since getting 2nd dose of Moderna vaccine,know it is due to how the injection was administered") in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 0660214) for COVID-19 vaccination. No Medical History information was reported. On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (has limited movement in left arm says can't use it to put seatbelt on), PYREXIA (feverish) and VACCINATION SITE PAIN (left arm pain since getting 2nd dose of Moderna vaccine,know it is due to how the injection was administered"). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (has limited movement in left arm says can't use it to put seatbelt on), PYREXIA (feverish) and VACCINATION SITE PAIN (left arm pain since getting 2nd dose of Moderna vaccine,know it is due to how the injection was administered") outcome was unknown. Concomitant medications was not provided by the reporter. Treatment: heating pad.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm; A little bit of tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (A little bit of tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immune system disorder NOS (Autoimmune).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (A little bit of tiredness). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (A little bit of tiredness) had resolved.            Concomitant product use was not provided by the reporter.  No treatment information was provided. It was reported that the patient did not have any issues at the time of reporting.   This case was linked to MOD-2021-406181, MOD-2021-406185 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pruritus
Clinical narrative: itchy bump on the injection site; Itchy bump on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy bump on the injection site) and VACCINATION SITE MASS (Itchy bump on the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, the patient experienced VACCINATION SITE PRURITUS (itchy bump on the injection site) and VACCINATION SITE MASS (Itchy bump on the injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy bump on the injection site) and VACCINATION SITE MASS (Itchy bump on the injection site) had not resolved.            Concomitant medications were not reported.  Treatment medications were not reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Back started itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Back started itching) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Neurontin. Past adverse reactions to the above products included Hallucination with Neurontin. Concurrent medical conditions included Anemic. Concomitant products included FOLIC ACID for Anemic.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PRURITUS (Back started itching). At the time of the report, PRURITUS (Back started itching) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medication was not provided.   This case was linked to MOD-2021-406143, MOD-2021-406209 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Fatigue, Myalgia
Clinical narrative: Chest Pain; Tired; Body aches; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt weak), CHEST PAIN (Chest Pain), FATIGUE (Tired) and MYALGIA (Body aches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 0441321A) for COVID-19 vaccination.     The patient's past medical history included Sickness (Patient may have had Covid-19 in February 2020 he was very sick at that time. Not diagnosed as Covid-19) in February 2020.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced ASTHENIA (Felt weak), FATIGUE (Tired) and MYALGIA (Body aches). On an unknown date, the patient experienced CHEST PAIN (Chest Pain). At the time of the report, ASTHENIA (Felt weak), FATIGUE (Tired) and MYALGIA (Body aches) outcome was unknown and CHEST PAIN (Chest Pain) had resolved.            No concomitant medications were provided. No treatment medications were taken by the patient.   This case was linked to MOD-2021-406148, MOD-2021-406203 (Patient Link).
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received dose about 2 weeks too soon; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received dose about 2 weeks too soon) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer vaccine (The first dose was given on 25-May-2021 and the second dose was given on 15-Jun-2021.) from 25-May-2021 to 15-Jun-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received dose about 2 weeks too soon). On 03-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received dose about 2 weeks too soon) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.    This case was linked to MOD-2021-406059 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: punctured more than 12 hours ago.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (punctured more than 12 hours ago.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (punctured more than 12 hours ago.). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (punctured more than 12 hours ago.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications were not reported. treatment medications were not reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Nervousness, Pain, Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Horrible itching situation on her arms and legs/pretty bad for so many weeks/every once in a while get bumps that hurt/and then itch), PAIN (Bumps that hurt), ASTHENIA (Debilitating at times) and NERVOUSNESS (Weary and nervous about the booster) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Horrible itching situation on her arms and legs/pretty bad for so many weeks/every once in a while get bumps that hurt/and then itch), PAIN (Bumps that hurt), ASTHENIA (Debilitating at times) and NERVOUSNESS (Weary and nervous about the booster). At the time of the report, PRURITUS (Horrible itching situation on her arms and legs/pretty bad for so many weeks/every once in a while get bumps that hurt/and then itch) and PAIN (Bumps that hurt) had not resolved and ASTHENIA (Debilitating at times) and NERVOUSNESS (Weary and nervous about the booster) outcome was unknown.            No Concomitant information was reported. No Treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: the last vial in the box was opened/booster doses administered from vial that had not been properly disposed; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the last vial in the box was opened/booster doses administered from vial that had not been properly disposed) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (the last vial in the box was opened/booster doses administered from vial that had not been properly disposed). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (the last vial in the box was opened/booster doses administered from vial that had not been properly disposed) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported.  No treatment medication details was reported.  The last vial in the box was opened on 02-Nov-2021.   The last vial in the box was opened on 19-Nov-2021. On 30-Nov-2021, it was found that a vial that had not been properly disposed of, thought it was a current viable vial, and gave booster doses from that vial.
Age: 81.0
Sex: U
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sore throat; This spontaneous case was reported by an other health care professional and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (she had the norms: fatique and vomiting) and VOMITING (she had the norms: fatique and vomiting) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (she had the norms: fatique and vomiting) and VOMITING (she had the norms: fatique and vomiting). At the time of the report, FATIGUE (she had the norms: fatique and vomiting) and VOMITING (she had the norms: fatique and vomiting) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications reported No Treatment medications reported   This case was linked to MOD-2021-404356, MOD-2021-406255 (Patient Link).